control group:docetaxel + cisplatin + fluorouracil

2 trials

Sponsors

West China Hospital, Sichuan University, Sichuan Cancer Hospital

Conditions

Locally advanced head and neck squamous cell carcinomanasopharyngeal carcinoma

Phase 3

Induction chemotherapy with GP versus TPF in III-IVA nasopharyngeal carcinoma: a randomized controlled trial

Active, not recruitingChiCTR1900022288

West China Hospital, Sichuan Universitynasopharyngeal carcinoma

Start: 2020-08-01Updated: 2019-04-08

Phase 4

A multicenter, open-label, randomized controlled clinical trail of PD-1 inhibitor (Toripalimab) combined with TPF chemotherapy for neoadjuvant treatment of locally advanced head and neck squamous cell carcinoma

RecruitingChiCTR2100045556

Sichuan Cancer HospitalLocally advanced head and neck squamous cell carcinoma

Start: 2021-04-14Updated: 2022-04-04